Price, David
Fromer, Leonard
Kaplan, Alan
van der Molen, Thys
Román-Rodríguez, Miguel
Article History
Received: 19 July 2013
Revised: 14 February 2014
Accepted: 28 March 2014
First Online: 17 July 2014
Competing interests
: DP: a member of advisory boards for Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Meda, Merck, Mundipharma, Napp, Novartis, Nycomed, Pfizer, Sandoz and Teva; grants and support for research in respiratory disease from the following organisations in the past 5 years: UK National Health Service, Aerocrine, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Novartis, Nycomed, Orion, Pfizer and Teva; consultancy for Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Meda, Merck, Mundipharma, Napp, Novartis, Nycomed, Pfizer, Sandoz and Teva; speaker fees from Activaero, Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Merck, Mundipharma, Novartis, Pfizer and Teva; payment for manuscript preparation from Merck, Mundipharma and Teva; payment for the development of educational materials from GlaxoSmithKline; stock/stock options in AKL International; payment for travel/accommodations/meeting expenses from Boehringer Ingelheim, Mundipharma, Napp and Novartis. LF: speaker bureau for Boehringer Ingelheim. AK: advisory boards or speaker bureau for AstraZeneca, Boehringer Ingelheim, Merck Frosst, Novartis, Pfizer, Purdue, Sanofi and Takeda. TvdM: research grants from Almirall, AstraZeneca, GlaxoSmithKline, MSD and Nycomed; consultancy fees for advisory boards from Almirall, AstraZeneca, MDS, Novartis and Nycomed; speaker fees from AstraZeneca, GlaxoSmithKline, MDS, Novartis and Nycomed. MRR: consultancy for Almirall, Boehringer Ingelheim, Chiesi and Novartis; speaker fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline and Novartis.